← Open Payments lookup

ELISE COLEMAN: Open Payments

NPI 1346945904 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$491 in 22 payments from 13 companies in 2025. Trend: 2023 $254 · 2024 $509 · 2025 $491

Food & beverage: $491
CompanyPaymentsAmount
Astellas Pharma US Inc4$100
Merck Sharp & Dohme LLC4$74
Deciphera Pharmaceuticals Inc.2$55
Regeneron Healthcare Solutions, Inc.2$51
Exelixis Inc.2$38
Takeda Pharmaceuticals U.S.A., Inc.1$25
AstraZeneca Pharmaceuticals LP1$24
Geron Corporation1$23
PFIZER INC.1$22
Karyopharm Therapeutics Inc.1$21

Products named: Vyloy, KEYTRUDA, QINLOCK, LIBTAYO, XTANDI, CABOMETYX, ICLUSIG, ENHERTU.

Industry payments across TX — which companies pay providers there.